Dental Pulp Stem Cell-Derived Exosomes Alleviate Mice Knee Osteoarthritis by Inhibiting TRPV4-Mediated Osteoclast Activation
International Journal of Molecular Sciences · 03.03.2023 · 24 (5) · 4926
DOI: 10.3390/ijms24054926 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.03.2023. Verfasst von Yu Fu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Fourth Clinical Division, Peking University School and Hospital of Stomatology, National Center for Stomatology, National Clinical Research Center fo…. Hauptthemen laut MEDLINE: Osteoarthritis, Knee, Exosomes, Cartilage, Articular. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Postdoctoral Fellowship of Peking-Tsinghua Center for Life Sciences.
Abstract (Originalsprache)
Osteoarthritis (OA) is a degenerative disease that causes chronic pain and joint swelling and even disables millions of patients. However, current non-surgical treatment for OA can only relieve pain without obvious cartilage and subchondral bone repair. Mesenchymal stem cell (MSC)-secreted exosomes have promising therapeutic effects on knee OA, but the efficacy of MSC-exosome therapy is not well determined, and the mechanisms involved are still unclear. In this study, we isolated dental pulp stem cell (DPSC)-derived exosomes by ultracentrifugation and determined the therapeutic effects of a single intra-articular injection of DPSC-derived exosomes in a mice knee OA model. The results showed that the DPSC-derived exosomes effectively improved abnormal subchondral bone remodeling, inhibited the occurrence of bone sclerosis and osteophytes, and alleviated cartilage degradation and synovial inflammation in vivo. Moreover, transient receptor potential vanilloid 4 (TRPV4) was activated during the progression of OA. Enhanced TRPV4 activation facilitated osteoclast differentiation, and TRPV4 inhibition blocked this process in vitro. DPSC-derived exosomes repressed osteoclast activation in vivo by inhibiting TRPV4 activation. Our findings demonstrated that a topical, single injection of DPSC-derived exosomes is a potential strategy for knee OA treatment, and that the exosomes regulated osteoclast activation by TRPV4 inhibition, which may act as a promising target for clinical OA treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fourth Clinical Division, Peking University School and Hospital of Stomatology, National Center for Stomatology, National Clinical Research Center for Oral Diseases, National Engineering Research Center of Oral Biomater…
- Department of Orthodontics, Peking University School and Hospital of Stomatology, National Center for Stomatology, National Clinical Research Center for Oral Diseases, National Engineering Research Center of Oral Biomat…
ORCID-Profile: Yu Fu
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Postdoctoral Fellowship of Peking-Tsinghua Center for Life Sciences
- Postdoctoral Fellowship of the Peking-Tsinghua Center for Life Sciences
Zitieren
APA
Fu, Y., Cui, S., Zhou, Y., & Qiu, L. (2023). Dental Pulp Stem Cell-Derived Exosomes Alleviate Mice Knee Osteoarthritis by Inhibiting TRPV4-Mediated Osteoclast Activation. International Journal of Molecular Sciences, 24(5), 4926. https://doi.org/10.3390/ijms24054926
Vancouver
Fu Y, Cui S, Zhou Y, Qiu L. Dental Pulp Stem Cell-Derived Exosomes Alleviate Mice Knee Osteoarthritis by Inhibiting TRPV4-Mediated Osteoclast Activation. International Journal of Molecular Sciences. 2023;24(5):4926. doi:10.3390/ijms24054926
BibTeX
@article{Fu2023,
author = {Fu, Yu and Cui, Shengjie and Zhou, Yanheng and Qiu, Lixin},
title = {Dental Pulp Stem Cell-Derived Exosomes Alleviate Mice Knee Osteoarthritis by Inhibiting TRPV4-Mediated Osteoclast Activation},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {5},
pages = {4926},
doi = {10.3390/ijms24054926}
}
EUVIMED